Weekly CEO Buys Highlights

CEOs' largest buys include Akamai, Ryman, OPKO, Cree

Author's Avatar
Oct 24, 2016
Article's Main Image

According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below:

Akamai Technologies CEO bought 18,276 shares

Akamai Technologies Inc. (AKAM, Financial) CEO F. Thomson Leighton bought 18,276 shares for $54.70 per share on Oct. 17. The stock price has increased by 5.43% since.

Akamai provides cloud services for delivering, optimizing and securing online content and business applications. It has a market cap of $10.08 billion. Its shares traded at $57.67 per share as of Oct. 21Â with a price-earnings (P/E) ratio of 31.65.

GAAP net income was $74 million, a 10% increase from the second quarter of 2015. Non-GAAP net income was $112 million, a 10% increase from second quarter 2015.

Executive Vice President and General Counsel Melanie Haratunian sold 12,129 shares for $56 per share on Oct. 5 and sold 2,575 shares for $56 per share on Oct. 18. The stock price has increased by 2.98% since.

Ryman Hospitality Properties CEO bought 8,040 shares

Ryman Hospitality Properties Inc. (RHP, Financial) Chairman and CEO Colin V. Reed bought 8,040 shares for $49.75 per share on Oct. 14. The stock price has decreased by 0.92% since.

Ryman operates as a real estate investment trust specializing in group-oriented, destination hotel assets in urban and resort markets. The company has a market cap of $2.49 billion. Its shares traded at $49.29 per share as of Oct. 21Â with a P/E ratio of 17.74.

Total revenue for the second quarter was $296.215 million compared to $274.036 million from the prior-year period.

OPKO Health CEO bought 24,600 shares

OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% owner Phillip Frost bought 24,600 shares in the past week for $9.29 per share. The stock price has increased by 1.08%.

OPKO is a biopharmaceutical and diagnostics company. It is engaged in the research and development of pharmaceutical products and vaccines. The company has a market cap of $5.23 billion. Its shares traded at $9.39 per share as of Oct. 21Â with a P/E ratio of 39.29.

Net income was $15.5 million for the quarter ending June 30, compared to net losses of $42.8 million for the comparable period of 2015. Consolidated revenue increased to $357.1 million from $42.4 million for the quarter ending June 30 compared to the 2015 period.

Frost bought 1,800 shares for $9.48 per share on Oct. 14; 3,600 shares for $9.34 per share on Oct. 17; 1,800 shares for $9.29 per share on Oct 18; and 14,700 shares for $9.26 per share on Oct. 19. Frost bought 2,700 shares for $9.26 per share on Oct. 20. The stock price has increased by 1.4% since.

Cree CEO bought 10,000 shares

Cree Inc. (CREE, Financial) Chairman, President and CEO Charles M. Swoboda bought 10,000 shares for $22.22 per share on Oct. 20. The stock price has decreased by 0.45%.

Cree manufactures lighting-class light emitting diode (LED) products, lighting products and bandgap semiconductor products for power and radio-frequency (RF) applications. The company has a market cap of $2.21 billion. Its shares traded at $22.12 per share on Oct. 21Â with a P/E ratio of 632.00.

Revenue from continuing operations was $321 million in the first quarter of 2017 compared to revenue from continuing operations of $381 million in the first quarter of fiscal 2016.

Director John B. Replogle bought 5,000 shares for $22.34 per share on Oct. 20. The stock price has decreased by 0.98% since.

For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Start a free seven-day trial of Premium Membership to GuruFocus.